{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:38:17Z","timestamp":1788255497438,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,9,21]],"date-time":"2011-09-21T00:00:00Z","timestamp":1316563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00431-011-1569-4","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T09:47:54Z","timestamp":1316512074000},"page":"463-470","source":"Crossref","is-referenced-by-count":17,"title":["Antibody persistence for 3\u00a0years following two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children"],"prefix":"10.1007","volume":"171","author":[{"given":"Markus","family":"Knuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Zepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Prieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Kieninger-Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Douha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,21]]},"reference":[{"key":"1569_CR1","unstructured":"Advisory Committee on Immunization Practices. June 29\u201330, 2006. Atlanta, Georgia. Record of the proceedings. http:\/\/www.cdc.gov\/vaccines\/recs\/acip\/meetings.htm#min . Accessed 25 October 2010"},{"key":"1569_CR2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.inf.0000219484.55858.a2","volume":"25","author":"A Arvin","year":"2006","unstructured":"Arvin A, Gershon A (2006) Control of varicella: why is a two-dose schedule necessary? Pediatr Infect Dis J 25:475\u2013476","journal-title":"Pediatr Infect Dis J"},{"key":"1569_CR3","volume-title":"Australian immunisation handbook","author":"Australian Government","year":"2008","unstructured":"Australian Government, Department of Health and Ageing, National Health and Medical Research Council (2008) Australian immunisation handbook, 9th edn. National Health and Medical Research Council, Canberra","edition":"9"},{"key":"1569_CR4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.4161\/hv.9898","volume":"5","author":"K Banz","year":"2009","unstructured":"Banz K, Iseli A, Aebi C, Brunner M, Schmutz AM, Heininger U (2009) Economic evaluation of varicella vaccination in Swiss children and adolescents. Hum Vaccin 5:847\u2013857","journal-title":"Hum Vaccin"},{"key":"1569_CR5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10198-003-0200-7","volume":"5","author":"K Banz","year":"2004","unstructured":"Banz K, Wagenpfeil S, Neiss A, Hammerschmidt T, Wutzler P (2004) The burden of varicella in Germany: potential risks and economic impact. Eur J Health Econ 5:46\u201353","journal-title":"Eur J Health Econ"},{"key":"1569_CR6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1017\/S0950268802007720","volume":"129","author":"PY Boelle","year":"2009","unstructured":"Boelle PY, Hanslik T (2009) Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect 129:599\u2013606","journal-title":"Epidemiol Infect"},{"key":"1569_CR7","first-page":"175","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention","year":"2007","unstructured":"Centers for Disease Control and Prevention (2007) Varicella. In: Atkinson W, Hamborsky J, McIntyre L, Wolfe S (eds) Epidemiology and prevention of vaccine-preventable diseases, 10th edn. Public Health Foundation, Washington, pp 175\u2013196","edition":"10"},{"key":"1569_CR8","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","volume":"347","author":"K Galil","year":"2002","unstructured":"Galil K, Lee B, Strine T, Carraher C, Baughman AL, Eaton M, Montero J, Seward J (2002) Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 347:1909\u20131915","journal-title":"N Engl J Med"},{"key":"1569_CR9","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2004.04.004","volume":"22","author":"A Gil","year":"2004","unstructured":"Gil A, San-Martin M, Carrasco P, Gonz\u00e1lez A (2004) Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine 22:3947\u20133951","journal-title":"Vaccine"},{"key":"1569_CR10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s15010-007-6337-z","volume":"35","author":"P Goh","year":"2007","unstructured":"Goh P, Lim FS, Han HH, Willems P (2007) Safety and immunogenicity of early vaccination with two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine in healthy children from 9\u00a0months of age. Infection 35:326\u2013333","journal-title":"Infection"},{"key":"1569_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcv.2005.02.003","volume":"33","author":"C Grose","year":"2005","unstructured":"Grose C (2005) Varicella vaccination of children in the United States: assessment after the first decade 1995\u20132005. J Clin Virol 33:89\u201395","journal-title":"J Clin Virol"},{"key":"1569_CR12","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2007.08.017","volume":"25","author":"T Hammerschmidt","year":"2007","unstructured":"Hammerschmidt T, Bisanz H, Wutzler P (2007) Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis. Vaccine 25:7307\u20137312","journal-title":"Vaccine"},{"key":"1569_CR13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","volume":"368","author":"U Heininger","year":"2006","unstructured":"Heininger U, Seward JF (2006) Varicella. Lancet 368:1365\u20131376","journal-title":"Lancet"},{"key":"1569_CR14","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","volume":"191","author":"AO Jumaan","year":"2005","unstructured":"Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF (2005) Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002. J Infect Dis 191:2002\u20132007","journal-title":"J Infect Dis"},{"key":"1569_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1358\/dot.2008.44.4.1210755","volume":"44","author":"M Knuf","year":"2008","unstructured":"Knuf M, Faber J, Barth I, Habermehl P (2008) A combination vaccine against measles, mumps, rubella and varicella. Drugs Today (Barc) 44:279\u2013292","journal-title":"Drugs Today (Barc)"},{"key":"1569_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","volume":"25","author":"M Knuf","year":"2006","unstructured":"Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, Prieler A, Maurer H, Bisanz H, Tornieporth N, Descamps D, Willems P (2006) Immunogenicity and safety of two doses of tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children. Pediatr Infect Dis J 25:12\u201318","journal-title":"Pediatr Infect Dis J"},{"key":"1569_CR17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/0063030-200822060-00005","volume":"22","author":"H Kreth","year":"2008","unstructured":"Kreth H, Lee BW, Kosuwon P, Salazar J, Meurice F, Bock H (2008) VarilrixTM: 16\u00a0years of experience with the first refrigerator-stable varicella vaccine. BioDrugs 22:387\u2013402","journal-title":"BioDrugs"},{"key":"1569_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.2.5.3246","volume":"2","author":"B Kuter","year":"2006","unstructured":"Kuter B, Hoffman Brown ML, Hartzel J, Williams WR, EvesiKaren A, Black S, Shinefield H, Reisinger KS, Marchant CD, Sullivan BJ, Thear M, Klopfer S, Xu J, Gress JO, Sch\u00f6del F, Study Group for ProQuad (2006) Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad\u00ae). Hum Vaccin 2:205\u2013214","journal-title":"Hum Vaccin"},{"issue":"2","key":"1569_CR19","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","volume":"23","author":"B Kuter","year":"2004","unstructured":"Kuter B, Matthews H, Shinefield H et al (2004) Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J 23(2):132\u2013137","journal-title":"Pediatr Infect Dis J"},{"key":"1569_CR20","doi-asserted-by":"crossref","first-page":"e1548","DOI":"10.1542\/peds.2007-2031","volume":"121","author":"LE Lee","year":"2008","unstructured":"Lee LE, Ho H, Lorber E, Fratto J, Perkins S, Cieslak PR (2008) Vaccine-era varicella epidemiology and vaccine effectiveness in a public elementary school population, 2002\u20132007. Pediatrics 121:e1548\u2013e1554","journal-title":"Pediatrics"},{"key":"1569_CR21","doi-asserted-by":"crossref","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","volume":"117","author":"AS Lopez","year":"2006","unstructured":"Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL (2006) One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 117:e1070\u2013e1077","journal-title":"Pediatrics"},{"key":"1569_CR22","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, G\u00fcris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) (2007) Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56:1\u201340","journal-title":"MMWR Recomm Rep"},{"key":"1569_CR23","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","volume":"122","author":"M Marin","year":"2008","unstructured":"Marin M, Meissner HC, Seward JF (2008) Varicella prevention in the United States: a review of successes and challenges. Pediatrics 122:e744\u2013e751","journal-title":"Pediatrics"},{"key":"1569_CR24","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1128\/JCM.43.9.4847-4851.2005","volume":"43","author":"J Mauldin","year":"1990","unstructured":"Mauldin J, Carbone K, Hsu H, Yolken R, Rubin S (1990) Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays. J Clin Microbiol 43:4847\u20134851","journal-title":"J Clin Microbiol"},{"key":"1569_CR25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.inf.0000154323.20387.82","volume":"24","author":"D Miron","year":"2005","unstructured":"Miron D, Lavi I, Kitov R, Hendler A (2005) Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J 24:233\u2013236","journal-title":"Pediatr Infect Dis J"},{"key":"1569_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/171.1.13","volume":"171","author":"S Nader","year":"1995","unstructured":"Nader S, Bergen R, Sharp M, Arvin AM (1995) Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine. J Infect Dis 171:13\u201317","journal-title":"J Infect Dis"},{"key":"1569_CR27","first-page":"1","volume":"30","author":"National Advisory Committee on Immunization (NACI)","year":"2004","unstructured":"National Advisory Committee on Immunization (NACI) (2004) Update on varicella. Can Commun Dis Rep 30:1\u201326","journal-title":"Can Commun Dis Rep"},{"key":"1569_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00006454-199601000-00011","volume":"15","author":"AL Ngai","year":"1996","unstructured":"Ngai AL, Staehle BO, Kuter BJ, Cyanovich NM, Cho I, Matthews H, Keller P, Arvin AM, Watson B, White CJ (1996) Safety and immunogenicity of one vs. two injections of Oka\/Merck varicella vaccine in healthy children. Pediatr Infect Dis J 15:49\u201354","journal-title":"Pediatr Infect Dis J"},{"key":"1569_CR29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","volume":"352","author":"HQ Nguyen","year":"2005","unstructured":"Nguyen HQ, Jumaan AO, Seward JF (2005) Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352:450\u2013458","journal-title":"N Engl J Med"},{"key":"1569_CR30","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/adc.2007.126243","volume":"93","author":"J Quian","year":"2008","unstructured":"Quian J, R\u00fcttimann R, Romero C, Dall\u2019orso P, Cerisola A, Breuer T, Greenberg M, Verstraeten T (2008) Impact of universal varicella vaccination of one year-olds in Uruguay: 1997\u20132005. Arch Dis Child 93:845\u2013850","journal-title":"Arch Dis Child"},{"key":"1569_CR31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.323.7321.1091","volume":"323","author":"H Rawson","year":"2001","unstructured":"Rawson H, Crampin A, Noah N (2001) Deaths from chickenpox in England and Wales 1995\u20137: analysis of routine mortality data. BMJ 323:1091\u20131093","journal-title":"BMJ"},{"key":"1569_CR32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14760584.7.6.753","volume":"7","author":"MH Rozenbaum","year":"2008","unstructured":"Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ (2008) Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vaccines 7:753\u2013782","journal-title":"Expert Rev Vaccines"},{"key":"1569_CR33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/INF.0b013e318170bb22","volume":"27","author":"V Schuster","year":"2008","unstructured":"Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P (2008) Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J 27:724\u2013730","journal-title":"Pediatr Infect Dis J"},{"key":"1569_CR34","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0264-410X(00)00297-8","volume":"19","author":"RG Sharrar","year":"2000","unstructured":"Sharrar RG, LaRussa P, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA (2000) The postmarketing safety profile of varicella vaccine. Vaccine 19:916\u2013923","journal-title":"Vaccine"},{"key":"1569_CR35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.inf.0000160947.89942.30","volume":"24","author":"R Sheffer","year":"2005","unstructured":"Sheffer R, Segal D, Rahamani S, Dalal I, Linhart Y, Stein M, Shohat T, Somekh E (2005) Effectiveness of the Oka\/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel. Pediatr Infect Dis J 24:434\u2013437","journal-title":"Pediatr Infect Dis J"},{"key":"1569_CR36","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1093\/infdis\/174.Supplement_3.S330","volume":"174","author":"T Varis","year":"1996","unstructured":"Varis T, Vesikari T (1996) Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis 174:S330\u2013S334","journal-title":"J Infect Dis"},{"key":"1569_CR37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.inf.0000250689.09396.21","volume":"26","author":"T Vesikari","year":"2007","unstructured":"Vesikari T, Baer M, Willems P (2007) Immunogenicity and safety of a second dose of measles\u2013mumps\u2013rubella\u2013varicella vaccine in healthy children aged 5 to 6\u00a0years. Pediatr Infect Dis J 26:153\u2013158","journal-title":"Pediatr Infect Dis J"},{"key":"1569_CR38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/clinids\/20.2.316","volume":"20","author":"B Watson","year":"1995","unstructured":"Watson B, Boardman C, Laufer D, Piercy S, Tustin N, Olaleye D, Cnaan A, Starr SE (1995) Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin Infect Dis 20:316\u2013319","journal-title":"Clin Infect Dis"},{"key":"1569_CR39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jama.294.7.797","volume":"294","author":"F Zhou","year":"2005","unstructured":"Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A (2005) Impact of varicella vaccination on health care utilization. JAMA 294:797\u2013802","journal-title":"JAMA"},{"key":"1569_CR40","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","volume":"197","author":"F Zhou","year":"2008","unstructured":"Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF (2008) An economic analysis of the universal varicella vaccination program in the United States. J Infect Dis 197:S156\u2013S164","journal-title":"J Infect Dis"},{"key":"1569_CR41","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1542\/peds.108.1.79","volume":"108","author":"C Ziebold","year":"2001","unstructured":"Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ (2001) Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 108:E79","journal-title":"Pediatrics"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-011-1569-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-011-1569-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-011-1569-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:22:13Z","timestamp":1559082133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-011-1569-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,21]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1007\/s00431-011-1569-4","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,21]]}}}